首页> 外国专利> use of 3-carboxy-n-ethyl-n, n-dimethylpropan-1-ammonium or its pharmaceutically acceptable salt in the treatment of atherosclerosis

use of 3-carboxy-n-ethyl-n, n-dimethylpropan-1-ammonium or its pharmaceutically acceptable salt in the treatment of atherosclerosis

机译：3-羧基-n-乙基-n，n-二甲基丙烷-1-铵或其药学上可接受的盐在动脉粥样硬化治疗中的应用

页面导航

摘要
著录项
相似文献

摘要

"use of 3-carboxy-n-ethyl-n, n-dimethylpropan-1-ammonium or its pharmaceutically acceptable salt in the treatment of atherosclerosis" use of 3-carboxy-n-ethyl-n, n-dimethylpropan-1- ammonium and its pharmaceutically acceptable salts: 3-carboxy-n-ethyl-n, n-dimethylpropan-1-ammonium hydrogen fumarate and 3-carboxy-n-ethyl-n, n-dimethylpropan-1-ammonium hydrogen phosphate in the prevention and treatment of atherosclerosis.

机译：“ 3-羧基-n-乙基-n，n-二甲基丙烷-1-铵或其可药用盐在动脉粥样硬化的治疗中的用途” 3-羧基-n-乙基-n，n-二甲基丙烷-1-铵的用途及其药学上可接受的盐：预防和治疗中的3-羧基-n-乙基-n，n-二甲基丙烷-1-铵富马酸氢盐和3-羧基-n-乙基-n，n-二甲基丙烷-1-铵磷酸氢盐的防治的动脉粥样硬化。

著录项

公开/公告号BR112015014161A2

专利类型
公开/公告日2017-07-11

原文格式PDF
申请/专利权人 GRINDEKS A JOINT STOCK COMPANY;
展开▼

申请/专利号BR20151114161
发明设计人 DAINA GUSTINA;EDGARS LIEPINS;EINARS LOZA;ILMARS STONANS;IVARS KALVINS;JANIS KUKA;LOLA DAINA;MAIJA DAMBROVA;MARINA MAKRECKA;OSVALDS PUGOVICS;REINIS VILSKERSTS;SOLVEIGA GRINBERGA;VIKTORS ANDRIANOVS;
展开▼

申请日2013-12-19
分类号A61K31/197;A61P9/10;
国家 BR
入库时间 2022-08-21 13:40:12

相似文献

专利
外文文献
中文文献